Sfoglia per RIVISTA
AIDS (LONDON, ENGLAND)
Collezione ASL Città di Torino

  

Items : 19

Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort. in AIDS (London, England) / AIDS. 2025 Feb 1;39(2):143-152. doi: 10.1097/QAD.0000000000004042. Epub 2024 Oct 21.

2025
ASL Città di Torino

De Socio GV; Ricci E; Piconi S; Squillace N; Maggi P; Orofino G; Altobelli D; Santoro C; Guastavigna M; Menzaghi B; Salomoni E; Di Biagio A; dell'Omo M; Francisci D; Bonfanti P;

Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV. in AIDS (London, England) / AIDS. 2024 Mar 15;38(4):477-486. doi: 10.1097/QAD.0000000000003775. Epub 2023 Nov 7.

2024
ASL Città di Torino
AOU Città della Salute di Torino

Calcagno A; Di Perri G; Letendre SL; Bonora S; Imperiale D; Cavallo R; Pittaluga F; Croce M; Trunfio M; Sacchi A; Vai D;

People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they? in AIDS (London, England) / AIDS. 2024 Mar 1;38(3):430-434. doi: 10.1097/QAD.0000000000003766. Epub 2024 Feb 1.

2024
AOU Alessandria
ASL Città di Torino

Cascio A; Carleo MA; Piccica M; Bargiacchi O; Pontali E; Cenderello G; Sarchi E; Squillace N; Pellicano' GF; Ferrara S; Menzaghi B; Baldi F; Ricci E; Orofino G; Bartalucci C; De Socio GV; Bonfanti P; Di Biagio A;

Association between tight junction proteins and cognitive performance in untreated persons with HIV. in AIDS (London, England) / AIDS. 2024 Jul 15;38(9):1292-1303. doi: 10.1097/QAD.0000000000003923. Epub 2024 May 2.

2024
ASL Città di Torino

Bai F; Bono V; Borghi L; Bonazza F; Falcinella C; Vitaletti V; Miraglia F; Trunfio M; Calcagno A; Cusato J; Vegni E; d'Arminio Monforte A; Marchetti G;

Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV. in AIDS (London, England) / AIDS. 2024 Jul 1;38(8):1273-1275. doi: 10.1097/QAD.0000000000003902. Epub 2024 May 30.

2024
ASL Città di Torino

Trunfio M; Bonora S; di Perri G; Calcagno A;

Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people with HIV. in AIDS (London, England) / AIDS. 2023 May 1;37(6):925-934. doi: 10.1097/QAD.0000000000003493. Epub 2023 Jan 24.

2023
ASL Città di Torino

Mazzitelli M; Trunfio M; Milinkovic A; Castelli E; Sasset L; Leoni D; Salvucci M; Cazzaro R; Calcinoni I; Balducci P; Ribeiro GCQ; Filagrana G; Scaglione V; Cattelan AM;

Incident diabetes in course of antiretroviral therapy. in AIDS (London, England) / AIDS. 2023 Jul 1;37(8):1269-1276. doi: 10.1097/QAD.0000000000003548. Epub 2023 Mar 14.

2023
AOU Alessandria
ASL Città di Torino

Gulminetti R; Sarchi E; Cascio A; Pellicanò GF; Maggi P; Rusconi S; Celesia BM; Valsecchi L; Vichi F; Madeddu G; Martinelli CV; Socio GV; Molteni C; Orofino G; Ricci E; Menzaghi B; Squillace N; Taramasso L; Falasca K; Di Biagio A; Bonfanti P;

Use of self-prescribed medications and complementary medicines in a cohort of women with HIV. in AIDS (London, England) / AIDS. 2022 Mar 15;36(4):617-619. doi: 10.1097/QAD.0000000000003174.

2022
ASL Città di Torino

Mazzitelli M; Sasset L; Trunfio M; di Meco E; Frater A; Leoni D; Cattelan A;

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV. in AIDS (London, England) / AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853.

2021
ASL Città di Torino

Guaraldi G; Calza S; Milic J; Calcagno A; Focà E; Rota M; Renzetti S; Celotti A; Siano M; Celesia BM; Piconi S; de Socio GV; Cattelan AM; Orofino G; Riva A; Nozza S; di Perri G;

Factors associated with hospital admission for COVID-19 in HIV patients. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1983-1985. doi: 10.1097/QAD.0000000000002663.

2020
ASL Città di Torino

Di Biagio A; Ricci E; Calza L; Squillace N; Menzaghi B; Rusconi S; Orofino G; Bargiacchi O; Molteni C; Valsecchi L; Cenderello G; Ferrara S; Saracino A; Maggi P; Falasca K; Taramasso L; Bonfanti P;

Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1899-1906. doi: 10.1097/QAD.0000000000002601.

2020
ASL Città di Torino

Calcagno A; Di Perri G; Guastamacchia G; Bonora S; Borgogno E; Domini S; Atzori C; Nigra M; Mighetto L; Vai D; Rugge W; Trunfio M;

Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation. in AIDS (London, England) / AIDS. 2020 Mar 1;34(3):373-380. doi: 10.1097/QAD.0000000000002442.

2020
ASL Città di Torino

Di Perri G; Calcagno A; Bonora S; Ghisetti V; Lipani F; Gregori G; Pirriatore V; Mighetto L; Imperiale D; Gianella S; Audagnotto S; Atzori C; Milia MG; Lupia T;

HIV-1 detection in the olfactory mucosa of HIV-1-infected participants. in AIDS (London, England) / AIDS. 2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102.

2019
ASL Città di Torino

Di Perri G; Calcagno A; Bonora S; Amasio E; Zanusso G; Ghisetti V; Pirriatore V; Kincer LP; Imperiale D; Cassoni P; Catera S; Trunfio M; Allice T; Joseph SB; Bertero L;

2019
ASL Città di Torino

Castagna A; Rusconi S; Gulminetti R; Bonora S; Mazzola G; Quiros-Roldan ME; De Socio GV; Ladisa N; Carosella S; Cattelan A; Di Giambenedetto S; Mena M; Poli A; Galli L; Riva A;

Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio? in AIDS (London, England) / AIDS. 2018 May 15;32(8):1083-1084. doi: 10.1097/QAD.0000000000001784.

2018
ASL Città di Torino

Capetti AF; Orofino G; Paladini L; Sterrantino G; DiGiambenedetto S; De Socio GV; Cenderello G; Cossu MV; Rizzardini G;

Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. in AIDS (London, England) / AIDS. 2017 Jan 28;31(3):455-457. doi: 10.1097/QAD.0000000000001351.

2017
ASL Città di Torino

Bonfanti P; Madeddu G; Gulminetti R; Squillace N; Orofino G; Vitiello P; Rusconi S; Celesia BM; Maggi P; Ricci E;

2017
ASL Città di Torino

Bai F; Iannuzzi F; Merlini E; Borghi L; Tincati C; Trunfio M; Bini T; Monforte AD; Marchetti G;

Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir. in AIDS (London, England) / AIDS. 2016 Jun 1;30(9):1491-3. doi: 10.1097/QAD.0000000000001089.

2016
ASL Città di Torino

Smolders EJ; Kanter CT; Grintjes K; D'Avolio A; Di Perri G; van Crevel R; Drenth JP; Burger DM;

Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients. in AIDS (London, England) / AIDS. 2014 Apr 24;28(7):1071-4. doi: 10.1097/QAD.0000000000000194.

2014
ASL Città di Torino

Dentone C; Di Biagio A; Parodi A; Bozzano F; Fraccaro P; Signori A; Cenderello G; Mantia E; Orofino G; De Maria A; Filaci G; Fenoglio D;